Clinical Trial Update: A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating PEP08 in MTAP-deleted advanced or metastatic solid tumors is currently recruiting. The sponsor is PharmaEngine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PEP08

Snippet

Sponsor: PharmaEngine | Conditions: Advanced Solid Tumor, Solid Tumors | Phase 1 | Status: RECRUITING